1999
DOI: 10.1016/s0002-9440(10)65514-9
|View full text |Cite
|
Sign up to set email alerts
|

Human Vascular Adhesion Protein-1 in Smooth Muscle Cells

Abstract: Human vascular adhesion protein-1 (VAP-1) is a dualfunction molecule with adhesive and enzymatic properties. In addition to synthesis in endothelial cells1 In endothelial cells, VAP-1 is localized both in conspicuous cytoplasmic granules and on the luminal surface. Under physiological conditions, the synthesis of VAP-1 is most prominent in high endothelial venules (HEVs) of peripheral lymph node-type lymphatic organs, but it is also inducible in vessels at other locations in the setting of inflammation.2 In en… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
55
0

Year Published

2001
2001
2008
2008

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 74 publications
(60 citation statements)
references
References 38 publications
5
55
0
Order By: Relevance
“…It is therefore conceivable that in addition to soluble primary amines, Lox and SSAO may act on amino acids included in matrix proteins. In addition, considering our methodological approach and the size of arterial samples, it is not possible to establish the relationship between SSAO tissue expression and activity, but this has previously investigated in the work of Jaakkola et al (1999) and Andres et al (2001). In this context, further morphological, biochemical, and molecular investigations will be required to determine this relationship and the exact nature of the SSAO substrate(s) in the blood vessels.…”
Section: Discussionmentioning
confidence: 99%
“…It is therefore conceivable that in addition to soluble primary amines, Lox and SSAO may act on amino acids included in matrix proteins. In addition, considering our methodological approach and the size of arterial samples, it is not possible to establish the relationship between SSAO tissue expression and activity, but this has previously investigated in the work of Jaakkola et al (1999) and Andres et al (2001). In this context, further morphological, biochemical, and molecular investigations will be required to determine this relationship and the exact nature of the SSAO substrate(s) in the blood vessels.…”
Section: Discussionmentioning
confidence: 99%
“…VAP-1, an adhesion protein with the same primary structure as tissue-bound SSAO, has been located in the endothelial wall of the high endothelial venules (Bono et al 1999). Expressed in inflammatory conditions, it binds to lymphocytes and helps them to migrate between endothelial cells into lymphoid organs (Jaakkola et al 1999). The presence of SSAO IR in lymphatic vessels and brain microvessels (Castillo et al 1998), but not in endothelial cells of large blood vessels, might reflect its duality as an enzyme and an adhesion protein.…”
Section: Discussionmentioning
confidence: 99%
“…A vascular adhesion protein, VAP-1, with identical sequence to the tissue-bound SSAO has recently been described Bono et al 1998). Because VAP-1 is involved in lymphocyte migration to lymphoid organs, a new physiological role for SSAO in cellular trafficking has been suggested Jaakkola et al 1999).…”
mentioning
confidence: 99%
“…However, it is unclear how a SSAO inhibitor would affect the variety of cardiovascular and noncardiovascular pools of SSAO activity, including adipose and gastrointestinal tract smooth muscle, where the function of SSAO also remains undetermined (18). For example, the SSAO protein homolog vascular adhesion protein-1 (VAP-1) expressed in endothelial and vascular smooth muscle cells mediates lymphocyte binding (26,41). Whereas previous studies detect little to no SSAO activity in endothelial cell cultures (50), purified human and bovine brain microvessels possess concentrated SSAO activity with relatively high affinity for MA (11).…”
Section: Implications For Human Health: Pharmacological and Toxicologmentioning
confidence: 99%